2025-17050Notice

DEA Extends Surveillance on Mail-Order Drug Deals

Published Date: 9/5/2025

Notice

Summary

The DEA is asking to keep collecting info about mail order drug sales without changing the current form. This affects businesses that sell drugs by mail and helps the government keep track of these transactions. No new costs or deadlines are coming, just a smooth extension to keep things running.

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

Mail‑Order Drug Sellers: Reporting Continues

If you run a business that sells drugs by mail, the DEA will keep collecting the same information using the existing Report of Mail Order Transactions form. This is an extension without change, so there are no new costs or new reporting deadlines — you must continue submitting the same reports to help the government track these transactions.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
9/5/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register